Welcome to Amerise Pharmaceuticals Pvt Ltd

About Us

Amerise is a global research and innovation-driven Integrated pharmaceutical company focusing on the NDA, 505(B)(2), and complex formulations.


Core expertise includes development of injectables, ophthalmics, and oral dosage forms from ‘Concept to clinic‘.


Established in 2018 with an aim to contribute towards the well-being and improving the health of people around the globe through the provision of innovative and reliable pharmaceutical products and services.


Amerise Pharma offers proven expertise in providing regulatory-compliant support for development of 505(b)(2) products and filing support for Generic products which includes: pre-IND meeting with FDA, IND-enabling studies, product registation and management of clinical services


To become a global recognized as domestic and internationally integrated pharmaceutical company through Innovation, Quality and Competence.


To be a globally admired, innovative, well recognized, best-in-class reputable pharmaceutical company. Amerise will seek to enhance its enterprise value in a sustainable manner with top quality management.

Patent Flash

Application No. : IN202021042563

Ready to use stable liquid herbal composition

Key Highlight : Single Shot Herbal compostion for Immunity Enhansment

Priority date : 30-Sep-20

Application No. : WO2022091118, IN202021047025

Anti-vertigo compound and pharmaceutical compositions

Key Highlight : Fisrt molecule in Vertigo treatment with having no CNS side effect

Priority date : 20-Oct-20

Application No. : IN202121052192

Stable pharmaceutical composition of non-steroidal antiandrogens

Key Highlight : Single Dose Oral Delevery, with Non Inferinging compostion

Priority date : 15-Nov-21

Application No. : IN202221049977

Oral Pharmaceutical Composition

Key Highlight : Patient friendly Oral Delivery for childeren with Non Inferinging compostion

Priority date : 1-Sep-22

Key Figures


Global Presence – US, UK & India

0 +

Successful Collaborations

0 %


0 +

Dosage Forms

Complex Injectables, Complex Generics, 505 (b)(2), NDA, Ophthalmic, Oral, Infusion Bag, PFS, Nasal


NDA Out-licensed